Market Research Logo

Biotextiles Global Market - Forecast to 2023

Biotextiles Global Market - Forecast to 2023

Biomedical textiles are one of the fastest growing fields in technical textile industry. Biomedical textiles can be categorized into two types i.e. Medical textiles and Biotextiles. Medical textiles market include products such as wound dressing, bandages, surgical dressing, medical clothing, barrier fabrics, protective clothing, surgical masks, sterile scrubs, etc. The BioTextiles are the textiles composed of synthetic or natural fibres designed specifically for implant procedures where there performance depends on biocompatibility and biostability with tissue and biological fluids. BioTextiles are used as implantable fabrics or as components of implantable devices. BioTextiles are used in applications such as surgical mesh, stent grafts, surgical sutures, hernia repair fabrics, artificial skin, heart patch, heart valves, artificial tendons & ligaments, cosmetic surgery, tissue engineering, neurovascular conduits, etc.

This report concentrates on biotextiles that are used as implants or components of implantable devices. The non-implant textiles or devices are not considered in biotextiles global market report. The biotextiles market is classified based on manufacturing techniques, materials, applications and geography. By manufacturing technique, the market is segmented into woven textiles, non-woven textiles, braided textiles and knitted textiles. By materials, the market is segmented into Non-bioabsorbable textiles and Bioabsorbable textiles. By application, biotextiles market is segmented into cardiovascular, orthopedic, gynaecology & urology, general surgery and other applications.

The BioTextiles global market is expected to grow at mid single digit CAGR to reach $7,390.4 million by 2023. Among the Biotextiles product by manufacturing technique, the braided textiles segment dominates the market by occupying a largest share and woven textiles segment is the fastest growing market from 2016 to 2023. In the BioTextiles applications, General surgery held XX% share in 2016 expected to grow at a CAGR of X% to reach $XX million by 2023. Cardiovascular segment is the fastest growing market with a strong CAGR of X% from 2016 to 2023.

The Biotextiles global market based on geography is divided into North America, Europe, Asia-Pacific and Rest of the world. North American region commanded the largest revenue of $XX million in 2016 and expected to reach $XX million by 2023 at a CAGR of X%. A high prevalence of cardiovascular diseases (such as heart failure, cardiogenic shock, dilated cardiomyopathy, ventricular insufficiency, Valvular heart disease, and congenital heart diseases), orthopaedic disorders, increase in minimally invasive surgeries, cosmetic surgeries, growth in aging population and shortage of heart donor organs led the market growth in this region. However, Asia-Pacific is expected to grow at a CAGR of X% to reach $XX million by 2023 owing to the rapidly increasing aging population with high prevalence of cardiovascular diseases, orthopaedic diseases, improving healthcare infrastructure and rise in healthcare spending in the emerging countries, such as India and China.

The BioTextiles market is a highly fragmented market. Major players in BioTextiles market include ATEX Technologies, Inc. (U.S.), C.R.Bard, Inc. (U.S.), Confluent Medical Technologies (U.S.), Culzean Textile Solutions Ltd. (U.K.), Getinge Group (Maquet) (Sweden), J-Pac Medical (U.S.), Medtronic PLC (Ireland), Poly-Med, Inc. (U.S.), RUA Medical (U.K.), Terumo Corporation (vascutek) (Japan), U.S. Biodesign (U.S.), W.L. Gore & Associates Inc. (U.S.).

The report provides an in-depth market analysis of the above-mentioned segments across the following regions:

  • North America
  • U.S.
  • Others
  • Europe
  • Germany
  • U.K.
  • France
  • Others
  • Asia-Pacific
  • Japan
  • China
  • India
  • Others
  • Rest of the World (RoW)
  • Brazil
  • Rest of Latin America
  • Middle East & Others


1 EXECUTIVE SUMMARY
2 INTRODUCTION
2.1 KEY TAKEAWAYS
2.2 REPORT DESCRIPTION
2.3 MARKETS COVERED
2.4 STAKEHOLDERS
2.5 RESEARCH METHODOLOGY
2.5.1 MARKET SIZE ESTIMATION
2.5.2 MARKET BREAKDOWN AND DATA TRIANGULATION
2.5.3 SECONDARY SOURCES
2.5.4 PRIMARY SOURCES
2.5.5 KEY DATA POINTS FROM SECONDARY SOURCES
2.5.6 KEY DATA POINTS FROM PRIMARY SOURCES
2.5.7 ASSUMPTIONS
3 MARKET ANALYSIS
3.1 INTRODUCTION
3.2 MARKET SEGMENTATION
3.3 FACTORS INFLUENCING MARKET
3.3.1 DRIVERS AND OPPORTUNITIES
3.3.1.1 Increasing aging population
3.3.1.2 Increasing minimally invasive surgery
3.3.1.3 Increase in accidents and sports injuries
3.3.1.4 Technological advancements in fibres and fabrication methods
3.3.1.5 Increasing prevalence of life style diseases
3.3.1.6 Increase in cardiovascular diseases and heart failure
3.3.1.7 Demand for orthopedic implants
3.3.1.8 Growth in emerging countries
3.3.1.9 Growing healthcare budgetary allocation
3.3.2 RESTRAINTS AND THREATS
3.3.2.1 Limitations of biotextiles based products
3.3.2.2 Lack of skilled and trained professionals
3.3.2.3 Stringent regulatory processes for approval
3.3.2.4 Reimbursement issues in emerging countries
3.4 REGULATORY AFFAIRS
3.4.1 INTERNATIONAL ORGANIZATION FOR STANDARDIZATION
3.4.1.1 ISO 9001: 2015 quality management system
3.4.1.2 ISO 13485 medical devices
3.4.1.3 ISO 10993 biological evaluation of medical devices
3.4.1.4 ISO 14644-1 clean room standards
3.4.2 ASTM INTERNATIONAL STANDARDS
3.4.3 U.S.
3.4.4 CANADA
3.4.5 EUROPE
3.4.6 JAPAN
3.4.7 CHINA
3.4.8 INDIA
3.5 PORTER’S FIVE FORCE ANALYSIS
3.5.1 THREAT OF NEW ENTRANTS
3.5.2 THREAT OF SUBSTITUTES
3.5.3 BARGAINING POWER OF SUPPLIERS
3.5.4 BARGAINING POWER OF BUYERS
3.5.5 RIVALRY AMONG EXISTING COMPETITORS
3.6 SUPPLY CHAIN ANALYSIS
3.7 MARKET SHARE ANALYSIS BY MAJOR PLAYERS
3.8 MATRIX OF BIOTEXTILES TYPE AND APPLICATIONS
3.9 BIOTEXTILES COMPANY COMPARISON TABLE BY TEXTILE TYPES, APPLICATIONS AND MATERIALS
4 BIOTEXTILES GLOBAL MARKET, BY MANUFACTURING TECHNIQUE
4.1 INTRODUCTION
4.2 WOVEN TEXTILES
4.3 NON-WOVEN TEXTILES
4.4 BRAIDED TEXTILES
4.5 KNITTED TEXTILES
5 BIOTEXTILES GLOBAL MARKET, BY MATERIAL
5.1 INTRODUCTION
5.2 NON-BIOABSORBABLE
5.3 BIOABSORBABLE
6 BIOTEXTILES GLOBAL MARKET, BY APPLICATION
6.1 INTRODUCTION
6.2 CARDIOVASCULAR
6.2.1 STENTS
6.2.2 STENT GRAFTS
6.2.3 HEART VALVE REPLACEMENT
6.2.4 HEART VALVE REPAIR
6.2.5 OTHERS
6.3 ORTHOPAEDIC
6.3.1 ARTIFICIAL LIGAMENTS AND TENDONS
6.3.2 SUTURES AND SUTURE ANCHORS
6.3.3 OTHERS
6.4 GYNAECOLOGY AND UROLOGY
6.4.1 INCONTINENCE SLINGS
6.4.2 PELVIC FLOOR REPAIR MESH
6.4.3 OTHERS
6.5 GENERAL SURGERY
6.5.1 SUTURES
6.5.2 HERNIA REPAIR MESH
6.5.3 COSMETIC SURGERY
6.5.4 OTHERS
6.6 OTHER APPLICATIONS
7 REGIONAL ANALYSIS
7.1 INTRODUCTION
7.2 NORTH AMERICA
7.2.1 U.S.
7.2.2 OTHERS
7.3 EUROPE
7.3.1 GERMANY
7.3.2 U.K.
7.3.3 FRANCE
7.3.4 OTHERS
7.4 APAC
7.4.1 JAPAN
7.4.2 CHINA
7.4.3 INDIA
7.4.4 OTHERS
7.5 ROW
7.5.1 BRAZIL
7.5.2 REST OF LATIN AMERICA
7.5.3 MIDDLE EAST AND OTHERS
8 COMPETITIVE LANDSCAPE
8.1 INTRODUCTION
9 MAJOR COMPANIES
9.1 ATEX TECHNOLOGIES, INC.
9.1.1 OVERVIEW
9.1.2 FINANCIALS
9.1.3 PRODUCT PORTFOLIO
9.1.4 KEY DEVELOPMENTS
9.1.5 BUSINESS STRATEGY
9.1.6 SWOT ANALYSIS
9.2 C.R.BARD
9.2.1 OVERVIEW
9.2.2 FINANCIALS
9.2.3 PRODUCT PORTFOLIO
9.2.4 KEY DEVELOPMENTS
9.2.5 BUSINESS STRATEGY
9.2.6 SWOT ANALYSIS
9.3 CONFLUENT MEDICAL TECHNOLOGIES
9.3.1 OVERVIEW
9.3.2 FINANCIALS
9.3.3 PRODUCT PORTFOLIO
9.3.4 KEY DEVELOPMENTS
9.3.5 BUSINESS STRATEGY
9.3.6 SWOT ANALYSIS
9.4 FENNER PLC (SECANT GROUP LLC)
9.4.1 OVERVIEW
9.4.2 FINANCIALS
9.4.3 PRODUCT PORTFOLIO
9.4.4 KEY DEVELOPMENTS
9.4.5 BUSINESS STRATEGY
9.4.6 SWOT ANALYSIS
9.5 GETINGE GROUP (MAQUET)
9.5.1 OVERVIEW
9.5.2 FINANCIALS
9.5.3 PRODUCT PORTFOLIO
9.5.4 KEY DEVELOPMENTS
9.5.5 BUSINESS STRATEGY
9.5.6 SWOT ANALYSIS
9.6 MEDTRONIC PLC
9.6.1 OVERVIEW
9.6.2 FINANCIALS
9.6.3 PRODUCT PORTFOLIO
9.6.4 KEY DEVELOPMENTS
9.6.5 BUSINESS STRATEGY
9.6.6 SWOT ANALYSIS
9.7 RUA MEDICAL
9.7.1 OVERVIEW
9.7.2 FINANCIALS
9.7.3 PRODUCT PORTFOLIO
9.7.4 KEY DEVELOPMENTS
9.7.5 BUSINESS STRATEGY
9.7.6 SWOT ANALYSIS
9.8 TERUMO CORPORATION (VASCUTEK LTD.)
9.8.1 OVERVIEW
9.8.2 FINANCIALS
9.8.3 PRODUCT PORTFOLIO
9.8.4 KEY DEVELOPMENTS
9.8.5 BUSINESS STRATEGY
9.8.6 SWOT ANALYSIS
9.9 US BIODESIGN, LLC
9.9.1 OVERVIEW
9.9.2 FINANCIALS
9.9.3 PRODUCT PORTFOLIO
9.9.4 KEY DEVELOPMENTS
9.9.5 BUSINESS STRATEGY
9.9.6 SWOT ANALYSIS
9.10 W.L.GORE & ASSOCIATES, INC.
9.10.1 OVERVIEW
9.10.2 FINANCIALS
9.10.3 PRODUCT PORTFOLIO
9.10.4 KEY DEVELOPMENTS
9.10.5 BUSINESS STRATEGY
9.10.6 SWOT ANALYSIS

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report